Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30,473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment Outcomes of Rituximab Plus Hyper-CVAD in Korean Patients with Sporadic Burkitt or Burkitt-like Lymphoma: Results of a Multicenter Analysis.
Hong J, Kim SJ, Ahn JS, Song MK, Kim YR, Lee HS, Yhim HY, Yoon DH, Kim MK, Oh SY, Park Y, Mun YC, Do YR, Ryoo HM, Lee JJ, Lee JH, Kim WS, Suh C. Hong J, et al. Among authors: lee hs, lee jh, lee jj. Cancer Res Treat. 2015 Apr;47(2):173-81. doi: 10.4143/crt.2014.055. Epub 2014 Oct 28. Cancer Res Treat. 2015. PMID: 25544581 Free PMC article.
High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study.
Bang SM, Cho EK, Suh C, Yoon SS, Seong CM, Cho KS, Kang YG, Park S, Ahn MJ, Park YS, Oh D, Kim HC, Jung CW, Kim S, Lee JH. Bang SM, et al. Among authors: lee jh. J Korean Med Sci. 2003 Oct;18(5):673-8. doi: 10.3346/jkms.2003.18.5.673. J Korean Med Sci. 2003. PMID: 14555819 Free PMC article. Clinical Trial.
Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer.
Park SH, Lee J, Lee SH, Park JO, Kim K, Kim WS, Jung CW, Park YS, Kang WK, Park K, Kim S, Bang SM, Cho EK, Shin DB, Lee JH. Park SH, et al. Among authors: lee sh, lee j, lee jh. Cancer Chemother Pharmacol. 2006 Jan;57(1):91-6. doi: 10.1007/s00280-005-0027-2. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16088407
A pilot study of bortezomib in Korean patients with relapsed or refractory myeloma.
Lee KW, Yun T, Song EK, Na II, Shin H, Bang SM, Lee JH, Lee ST, Kim JH, Yoon SS, Lee JS, Park S, Kim BK, Kim NK. Lee KW, et al. Among authors: lee js, lee jh, lee st. J Korean Med Sci. 2005 Aug;20(4):598-62. doi: 10.3346/jkms.2005.20.4.598. J Korean Med Sci. 2005. PMID: 16100450 Free PMC article. Clinical Trial.
A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma.
Bang SM, Lee JH, Yoon SS, Park S, Min CK, Kim CC, Suh C, Sohn SK, Min YH, Lee JJ, Kim K, Seong CM, Yoon HJ, Cho KS, Jo DY, Lee KH, Lee NR, Kim CS; Korean Multiple Myeloma Working Party. Bang SM, et al. Among authors: lee nr, lee kh, lee jh, lee jj. Int J Hematol. 2006 May;83(4):309-13. doi: 10.1532/IJH97.A30512. Int J Hematol. 2006. PMID: 16757429
Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma.
Park BB, Ryoo BY, Lee JH, Kwon HC, Yang SH, Kang HJ, Kim HJ, Oh SY, Ko YH, Huh JR, Lee SS, Nam EM, Park KW, Kim JH, Kang JH, Bang SM, Park S, Kim K, Park K, Suh C, Kim WS. Park BB, et al. Among authors: lee jh, lee ss. Leuk Lymphoma. 2007 Apr;48(4):716-22. doi: 10.1080/10428190601123989. Leuk Lymphoma. 2007. PMID: 17454629
30,473 results
You have reached the last available page of results. Please see the User Guide for more information.